CME Group Inc.
DE ˙ XTRA ˙ US12572Q1058
217,80 € ↑3,15 (1,47%)
2026-06-03
AKTIENPREIS
SecurityDE:MX4A / CME Group Inc.
InstitutionBelpointe Asset Management LLC
Latest Disclosed Ownership6,132 shares
Latest Disclosed Value $ 1,811,141
Belpointe Asset Management LLC reports 19.33% decrease in ownership of MX4A / CME Group Inc.

On April 28, 2026 - Belpointe Asset Management LLC filed a 13F-HR form disclosing ownership of 6,132 shares of CME Group Inc. (DE:MX4A) valued at $1,566,419 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 7,601 shares of CME Group Inc.. This represents a change in shares of -19.33% during the quarter. The current value of the position is $1,335,550 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F CME GROUP COM 12572Q105 6,132 -1,469 -19.33 1,811 -12.72 0.0661
2026-01-27 2025-12-31 13F CME GROUP COM 12572Q105 7,601 891 13.28 2,076 14.45 0.0750
2025-11-03 2025-09-30 13F CME GROUP COM 12572Q105 6,710 -211 -3.05 1,813 -4.93 0.0693
2025-07-22 2025-06-30 13F CME GROUP COM 12572Q105 6,921 134 1.97 1,908 5.94 0.0795
2025-05-20 2025-03-31 13F CME GROUP COM 12572Q105 6,787 3,195 88.95 1,801 132.26 0.0937
2025-02-13 2024-12-31 13F CME GROUP COM 12572Q105 3,592 -14 -0.39 775 -2.52 0.0467
2024-11-13 2024-09-30 13F CME GROUP COM 12572Q105 3,606 431 13.57 796 27.40 0.0477
2024-08-02 2024-06-30 13F CME GROUP COM 12572Q105 3,175 -582 -15.49 624 -22.87 0.0435
2024-05-08 2024-03-31 13F CME GROUP COM 12572Q105 3,757 127 3.50 809 5.89 0.0606
2024-02-13 2023-12-31 13F CME GROUP COM 12572Q105 3,630 -94 -2.52 765 2.55 0.0672
2023-11-15 2023-09-30 13F CME GROUP COM 12572Q105 3,724 134 3.73 746 12.03 0.0772
2023-08-15 2023-06-30 13F CME GROUP COM 12572Q105 3,590 -1,070 -22.96 665 -25.45 0.0704
2023-05-15 2023-03-31 13F CME GROUP COM 12572Q105 4,660 1,639 54.25 893 75.94 0.0482
2023-02-08 2022-12-31 13F CME GROUP COM 12572Q105 3,021 -29 -0.95 508 -6.11 0.0307
2022-11-14 2022-09-30 13F CME GROUP COM 12572Q105 3,050 1,584 108.05 540 80.00 0.0365
2022-08-02 2022-06-30 13F CME GROUP COM 12572Q105 1,466 248 20.36 300 3.45 0.0201
2022-04-28 2022-03-31 13F CME GROUP COM 12572Q105 1,218 205 20.24 290 25.54 0.0176
2022-02-15 2021-12-31 13F CME GROUP COM 12572Q105 1,013 29 2.95 231 21.58 0.0144
2021-11-15 2021-09-30 13F CME GROUP COM 12572Q105 984 174 21.48 190 10.47 0.0130
2021-08-09 2021-06-30 13F CME GROUP COM 12572Q105 810 60 8.00 172 12.42 0.0124
2021-05-14 2021-03-31 13F CME GROUP COM 12572Q105 750 32 4.46 153 16.79 0.0131
2021-02-16 2020-12-31 13F CME GROUP COM 12572Q105 718 19 2.72 131 11.97 0.0118
2020-11-13 2020-09-30 13F/A-1 CME GROUP COM 12572Q105 699 -266 -27.56 117 -25.48 0.0130
2020-11-13 2020-09-30 13F CME GROUP COM 12572Q105 1,003 173
2020-07-20 2020-06-30 13F CME GROUP COM 12572Q105 965 -38 -3.79 157 -9.25 0.0203
2020-07-20 2020-03-31 13F CME GROUP COM 12572Q105 1,003 -417 -29.37 173 -39.30 0.0303
2020-02-18 2019-12-31 13F CME GROUP COM 12572Q105 1,420 -288 -16.86 285 -21.05 0.0362
2020-01-16 2019-09-30 13F CME GROUP COM 12572Q105 1,708 237 16.11 361 26.67 0.0584
2019-11-22 2019-06-30 13F CME GROUP COM 12572Q105 1,471 -129 -8.06 285 8.37 0.0561
2019-06-11 2019-03-31 13F CME GROUP COM CL A 12572Q105 1,600 -1,899 -54.27 263 -60.03 0.0514
2019-03-06 2018-12-31 13F CME GROUP COM CL A 12572Q105 3,499 1,770 102.37 658 123.81 0.1668
2018-11-23 2018-09-30 13F CME GROUP COM CL A 12572Q105 1,729 1,729 294 0.0465
2018-08-06 2018-06-30 13F CME GROUP COM CL A 12572Q105 0 -5,389 -100.00 0 -100.00
2018-08-06 2018-03-31 13F CME GROUP COM CL A 12572Q105 5,389 2,019 59.91 872 77.24 0.2542
2018-02-14 2017-12-31 13F CME GROUP COM CL A 12572Q105 3,370 571 20.40 492 29.47 0.1078
2017-11-16 2017-09-30 13F CME GROUP COM CL A 12572Q105 2,799 2,799 380 0.0889
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.